Paragon BioTeck, Inc. Press releases
Jun 25, 2014
PORTLAND, OR —Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today it has received 510(k) clearance from the U.S.